"I love TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company"

2022-05-05 10:54:56

contact 简 繁 About Us Company Profile Our Team Milestones R&D Discovery Translational Research Process Development Clinical Development Manufacturing T-BLOC ICB Platform Experience & Capacity Pipeline Oncology Non-oncology Collaborations Investors News Press Release In The News Scientific Publications Careers Life in Transcenta Job Opportunity About Us Company Profile Our Team Milestones R&D Discovery Translational Research Process Development Clinical Development Manufacturing T-BLOC ICB Platform Experience & Capacity Pipeline Oncology Non-oncology Investors News Press Release In The News Scientific Publications Careers Life in Transcenta Job Opportunity contact 简 繁 Innovate to excel Employing cutting-edge technology, we innovate to help patients with differentiated and affordable biologics. 您的浏览器不支持 video 标签。 Recent news 2022-04-29 Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting View details 2022-04-28 Transcenta Announces First Patient Dosed in China Study of Anti-sclerostin Monoclonal Antibody TST002 for the Treatment of Osteoporosis View details 2022-04-21 Transcenta Successfully Passed the Audit of EU Qualified Person for the Manufacturing of TST001 View details R&D Discovery Employing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate therapeutic candidate leads with differentiated biological profile and enhanced druggability attributes. Translational Research Our translational research platform enables us to model tumor responses to our investigational agents and to better understand PK/PD profiles, which guides design and conduct of clinical study. Process Development We can leverage both classical fed-batch and perfusion-based continuous bioprocessing technologies to enable fast-to-IND and fast-to-market process development. Clinical Development Based in Beijing, Shanghai, Guangzhou and Princeton, US, our teams at global clinical development centers and regulatory teams have extensive knowledge and experience in designing and executing clinical trials at all stages. Manufacturing Equipped with a flexible modular manufacturing facility and advanced next-generation perfusion bioprocessing platform, we are able to significantly accelerate process development and reduce the cost of manufacturing. Global Collaboration Benefited from the global network and industry resources of our prominent shareholders with deep biotech expertise, we have forged multiple forms of important strategic cooperation with leading domestic and international pharmaceutical companies and equipment suppliers. Explore more Explore more .indFour { background-image: url('/ch/templates/default/images/shape_wavy_lined.png'); } .indFour_box { display: flex; align-items: stretch; flex-wrap: wrap; }.indFour_item { width: 33%; padding-left: 4%; padding-right: 3%; } @media (max-width: 1201px) { .indFour { background-image: url('/ch/templates/default/images/cs1106.png'); } } @media(max-width:900px) { .indFour_item { float: none; width: 100%; padding: 0; margin-bottom: 40px; overflow: hidden;}.indFour_txt p{min-height: 80px;} } Stay tuned © 2019 TRANSCENTA HOLDING ALL RIGHTS RESERVED. 浙ICP备18056272号-1 About Us Company Profile Our Team Milestones R&D Discovery Translational Research Process Development Clinical Development Manufacturing T-BLOC ICB Platform Experience & Capacity Pipeline Oncology Non-oncology Collaborations Investors News Press Release In The News Scientific Publications Careers Life in Transcenta Job Opportunity 您的浏览器不支持 video 标签。